Immunological therapy in urological malignancy: Novel combination strategies

1Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

At present, immunotherapy in urological malignancy is experiencing a renaissance, particularly with the emergence of a host of innovative cancer vaccines. Herein, we will review promising immunotherapeutic approaches and evaluate the data supporting their inclusion in novel combination strategies. © 2010 The Japanese Urological Association.

Cite

CITATION STYLE

APA

Finley, D. S., Pouliot, F., Chin, A. I., Shuch, B., Pantuck, A. J., Belldegrun, A. S., & Dekernion, J. B. (2011, February). Immunological therapy in urological malignancy: Novel combination strategies. International Journal of Urology. https://doi.org/10.1111/j.1442-2042.2010.02664.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free